NYSE:VSI - Vitamin Shoppe Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$7.30 -0.05 (-0.68 %)
(As of 07/23/2018 11:37 AM ET)
Previous Close$7.30
Today's Range$7.18 - $7.30
52-Week Range$2.95 - $11.45
Volume3,668 shs
Average Volume281,570 shs
Market Capitalization$178.10 million
P/E Ratio18.85
Dividend YieldN/A
Beta0.5
Vitamin Shoppe logoVitamin Shoppe, Inc., through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products. It offers vitamins, minerals, herbs, specialty supplements, sports nutrition products, and other health and wellness products of approximately 900 brands, such as own brands comprising The Vitamin Shoppe, BodyTech, True Athlete, Mytrition, plnt, ProBioCare, Next Step, and Betancourt Nutrition; and national brands, including Optimum Nutrition, Cellucor, Garden of Life, Quest Nutrition, Solaray, Solgar, Megafood, and Nature's Way. The company sells its products through Vitamin Shoppe and Super Supplements retail stores, as well as through its vitaminshoppe.com Website. As of December 30, 2017, it operated through 785 Vitamin Shoppe and Super Supplements retail stores in 45 states, the District of Columbia, and Puerto Rico; and 8 franchise stores in Panama, 5 in Guatemala, 3 in Paraguay, and 2 in Costa Rica. The company was formerly known as VS Holdings, Inc. and changed its name to Vitamin Shoppe, Inc. in November 2009. Vitamin Shoppe, Inc. was founded in 1977 and is headquartered in Secaucus, New Jersey.

Receive VSI News and Ratings via Email

Sign-up to receive the latest news and ratings for VSI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Food stores
Sub-IndustrySpecialty Stores
SectorRetail/Wholesale
SymbolNYSE:VSI
CUSIP92849E10
Phone201-868-5959

Debt

Debt-to-Equity Ratio0.47
Current Ratio1.88
Quick Ratio0.44

Price-To-Earnings

Trailing P/E Ratio18.85
Forward P/E Ratio-31.74
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.18 billion
Price / Sales0.15
Cash Flow$13.5185 per share
Price / Cash0.54
Book Value$8.15 per share
Price / Book0.90

Profitability

EPS (Most Recent Fiscal Year)$0.39
Net Income$-252,150,000.00
Net Margins-22.80%
Return on Equity1.28%
Return on Assets0.56%

Miscellaneous

Employees5,573
Outstanding Shares24,230,000
Market Cap$178.10

Vitamin Shoppe (NYSE:VSI) Frequently Asked Questions

What is Vitamin Shoppe's stock symbol?

Vitamin Shoppe trades on the New York Stock Exchange (NYSE) under the ticker symbol "VSI."

How were Vitamin Shoppe's earnings last quarter?

Vitamin Shoppe Inc (NYSE:VSI) posted its quarterly earnings results on Wednesday, May, 9th. The specialty retailer reported $0.10 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.10. The specialty retailer earned $295.96 million during the quarter, compared to analyst estimates of $293.44 million. Vitamin Shoppe had a positive return on equity of 1.28% and a negative net margin of 22.80%. View Vitamin Shoppe's Earnings History.

When is Vitamin Shoppe's next earnings date?

Vitamin Shoppe is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Vitamin Shoppe.

What price target have analysts set for VSI?

5 analysts have issued 12 month price objectives for Vitamin Shoppe's shares. Their forecasts range from $3.00 to $7.00. On average, they expect Vitamin Shoppe's share price to reach $4.95 in the next year. This suggests that the stock has a possible downside of 32.2%. View Analyst Ratings for Vitamin Shoppe.

What is the consensus analysts' recommendation for Vitamin Shoppe?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vitamin Shoppe in the last year. There are currently 2 sell ratings and 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Who are some of Vitamin Shoppe's key competitors?

Who are Vitamin Shoppe's key executives?

Vitamin Shoppe's management team includes the folowing people:
  • Mr. Colin Frederick Watts, Chief Exec. Officer and Director (Age 52)
  • Ms. Brenda M. Galgano CPA, Chief Financial Officer and Exec. VP (Age 49)
  • Mr. David M. Kastin, Sr. VP, Gen. Counsel & Corp. Sec. (Age 50)
  • Mr. Alexander W. Smith, Exec. Chairman (Age 65)
  • Mr. John Hnanicek, Chief Customer Innovation & Technology Officer and Sr. VP

Has Vitamin Shoppe been receiving favorable news coverage?

Media coverage about VSI stock has trended somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Vitamin Shoppe earned a news impact score of 0.11 on Accern's scale. They also gave media coverage about the specialty retailer an impact score of 45.88 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are Vitamin Shoppe's major shareholders?

Vitamin Shoppe's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include VINTAGE CAPITAL MANAGEMENT LLC (17.70%), SHAH CAPITAL MANAGEMENT (17.70%), VINTAGE CAPITAL MANAGEMENT LLC (14.80%), AJ Wealth Strategies LLC (0.16%) and Nisa Investment Advisors LLC (0.08%). Company insiders that own Vitamin Shoppe stock include Alex Smith, B Michael Becker, Dan Lamadrid, Guillermo Marmol, John D Bowlin, Richard L Markee, Shah Capital Management and Vintage Capital Management Llc. View Institutional Ownership Trends for Vitamin Shoppe.

Which major investors are buying Vitamin Shoppe stock?

VSI stock was purchased by a variety of institutional investors in the last quarter, including AJ Wealth Strategies LLC and Nisa Investment Advisors LLC. Company insiders that have bought Vitamin Shoppe stock in the last two years include Alex Smith, Guillermo Marmol, John D Bowlin, Shah Capital Management and Vintage Capital Management Llc. View Insider Buying and Selling for Vitamin Shoppe.

How do I buy shares of Vitamin Shoppe?

Shares of VSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vitamin Shoppe's stock price today?

One share of VSI stock can currently be purchased for approximately $7.30.

How big of a company is Vitamin Shoppe?

Vitamin Shoppe has a market capitalization of $178.10 million and generates $1.18 billion in revenue each year. The specialty retailer earns $-252,150,000.00 in net income (profit) each year or $0.39 on an earnings per share basis. Vitamin Shoppe employs 5,573 workers across the globe.

How can I contact Vitamin Shoppe?

Vitamin Shoppe's mailing address is 300 HARMON MEADOW BLVD., SECAUCUS NJ, 07094. The specialty retailer can be reached via phone at 201-868-5959 or via email at [email protected]


MarketBeat Community Rating for Vitamin Shoppe (NYSE VSI)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  283 (Vote Outperform)
Underperform Votes:  438 (Vote Underperform)
Total Votes:  721
MarketBeat's community ratings are surveys of what our community members think about Vitamin Shoppe and other stocks. Vote "Outperform" if you believe VSI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VSI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/23/2018 by MarketBeat.com Staff

Featured Article: Closed-End Mutual Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.